trending Market Intelligence /marketintelligence/en/news-insights/trending/yebm4ho7utqizc_k5tmxjw2 content esgSubNav
In This List

Eleven Biotherapeutics regains compliance with Nasdaq listing requirements

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Eleven Biotherapeutics regains compliance with Nasdaq listing requirements

Eleven Biotherapeutics Inc. said it regained compliance with Nasdaq Stock Market LLC's $1 minimum bid price listing requirement.

The Cambridge, Mass.-based company received a noncompliance notice from the Nasdaq in December 2017 as the closing bid price of the company's common stock was below $1 per share for 30 consecutive business days.

Nasdaq confirmed that the company regained compliance after the closing bid price for its common stock had been at $1 per share or greater for a minimum of 10 consecutive business days.